Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Arvinas Inc and Pfizer Inc Announce ARV-471 Collaboration- Conference Call Transcript

Jul 22, 2021 / 12:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Arvinas-Pfizer Collaboration Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your host today, Randy Teel, Vice President, Corporate Development at Arvinas. Please go ahead.

Randy Teel
Arvinas, Inc. - VP of Corporate Development

Thank you, operator. Good morning, everyone, and thank you for joining us to discuss our strategic collaboration with Pfizer, focused on our ER-targeting protectorate, ARV-471. Earlier today, we issued a press release announcing the collaboration. That press release as well as the presentation for today's call can be accessed in the Investors section of Arvinas website and also on the Pfizer website.

With me today are Arvinas President and Chief Executive Officer, John Houston; Chief Financial Officer, Sean Cassidy; and Chief Medical Officer, Ron Peck. In addition, we're pleased to have our Pfizer colleagues: Andy Schmeltz,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot